Skip to content
Subscriber Only

Glaxo Executives Admit to Bribery, Tax Crimes, China Says

Some GlaxoSmithKline Plc executives have admitted to corruption in China, after authorities found evidence of serious commercial bribery and tax-related crimes, the government said.

Glaxo is suspected of trying to increase sales channels and prices by using avenues such as travel agencies to bribe or sponsor projects of government officials, medical associations, hospitals and doctors, and faking tax receipts, China’s Ministry of Public Security said on its website today. The company has found no evidence of bribery or corruption of doctors or officials in China, it said in an e-mailed statement.